abstract |
Methods of treating inflammation, post-reperfusion injury, microbial infections, vasculitis, leukemia, and methods of inhibiting the metastatic spread of tumor cells by administering a composition are provided. a pharmaceutical comprising a therapeutically effective amount of an antibody or antibody fragment against ELAM, and a pharmaceutically acceptable carrier. |